|Scores on PEDro scale*|
|Buroker and Schwane15||Soreness||-||+||?||?||-||-||-||+||?||+||+||4/10|
|Johansson et al16||Soreness||+||+||?||+||-||-||-||+||?||+||+||5/10|
|McGlynn et al17||Soreness||-||+||?||+||-||-||-||+||?||+||+||5/10|
|High et al18||Soreness||-||+||?||?||-||-||-||+||?||+||-||3/10|
|Wessel and Wan19||Soreness||-||+||?||+||-||-||-||?||?||+||+||4/10|
|Gulick et al20||Soreness||-||+||?||?||-||-||-||?||?||+||-||2/10|
|Pope et al21||Injury||+||+||?||+||-||-||+||+||+||+||+||7/10|
|Pope et al22||Injury||+||+||?||?||-||-||-||-||?||+||+||3/10|
↵* Column numbers correspond to the following criteria on the PEDro scale
eligibility criteria were specified
2subjects were randomly allocated to groups (or, in a crossover study, subjects were randomly allocated an order in which treatments were received)
3allocation was concealed.
4groups were similar at baseline
5subjects were blinded
6therapists who administered the treatment were blinded
7assessors were blinded
8measures of key outcomes were obtained from more than 85% of subjects
9data were analysed by intention to treat
10statistical comparisons between groups were conducted
11point measures and measures of variability were provided.
↵†The total score is determined by counting the number of criteria that are satisfied, except that scale item 1 is not used to generate the total score, so total scores are out of 10.
+ Indicates the criterion was clearly satisfied, - indicates that it was not, ? indicates that it is not clear if the criterion was satisfied.